Identification of oxazolidinediones and thiazolidinediones as potent 17β-hydroxysteroid dehydrogenase type 3 inhibitors
Authors:
- Koichiro HaradaKHKoichiro Harada
- Hideki KuboHKHideki Kubo
- Akio TanakaATAkio Tanaka
- Kazuhiko NishiokaKNKazuhiko Nishioka
- 1 January 2012
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 22 (1) , 504-507
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Design, Synthesis, and Biological Evaluation of N-Carboxyphenylpyrrole Derivatives as Potent HIV Fusion Inhibitors Targeting gp41Journal of Medicinal Chemistry, 2008
- The design of novel 17β-hydroxysteroid dehydrogenase type 3 inhibitorsMolecular and Cellular Endocrinology, 2008
- Identification of a novel series of tetrahydrodibenzazocines as inhibitors of 17β-hydroxysteroid dehydrogenase type 3Bioorganic & Medicinal Chemistry Letters, 2006
- Molecular characterization of human prostate carcinoma cell linesThe Prostate, 2003
- Inhibitors of 17β-Hydroxysteroid DehydrogenasesCurrent Medicinal Chemistry, 2003
- Differential expression of 17β‐hydroxysteroid dehydrogenase isozyme genes in prostate cancer and noncancer tissuesThe Prostate, 2002
- Synthesis and Optimization of a New Family of Type 3 17β-Hydroxysteroid Dehydrogenase Inhibitors by Parallel Liquid-Phase ChemistryJournal of Medicinal Chemistry, 2001
- A guide to 17β-hydroxysteroid dehydrogenasesMolecular and Cellular Endocrinology, 2001
- A New Convenient Synthesis of Hydantoin Derivatives by the Phase-Transfer MethodSynthesis, 1982
- The Carboxylation of Hydantoins1The Journal of Organic Chemistry, 1965